Investing.com and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Investing.com —The Federal Reserve is widely expected to hold interest rates steady this afternoon, keeping corporate borrowing costs near two-decade highs. For companies carrying heavy debt, that means another quarter of elevated refinancing expenses eating into net margins. For businesses that generate ample free cash and self-fund their operations, however, higher borrowing costs present little operational threat.
In an expensive credit environment, balance-sheet durability matters far more than rate forecasts. InvestingPro tracks market leaders with high interest coverage, robust cash conversion, and valuation discounts that provide a clear margin of safety. Ahead of the November rebalance, the models have isolated a concentrated basket of proven wealth generators—including global logistics monopolies, pharmaceutical leaders, and two deeply discounted blue chips generating billions in organic cash flow.
Position ahead of the November update: Explore the Quality Compounders strategy on InvestingPro
High-margin recurring revenue at an unusual valuation discount
Software sector jitters and scrutiny over artificial intelligence return on investment have dragged Adobe Inc (NASDAQ:ADBE)down 28% over the past year to trade near $249.07. Yet that skepticism overlooks what the business actually produces, earning Adobe a "Great" Financial Health rating on InvestingPro.
Operating with gross margins of 89.3%, Adobe generated $25.97 billion in revenue over the trailing twelve months alongside $9.43 billion in operating income. Crucially for a high-rate environment, the digital media company does not depend on debt markets to fund its operations. Adobe holds $5.64 billion in cash and short-term investments against $6.79 billion in total debt, while operating cash flows reached $10.81 billion over the past year. That supported $10.59 billion in free cash flow, representing a robust 10.9% free cash flow yield with interest coverage exceeding 40 times.
Trading at just 10.3 times forward earnings, the valuation has shrunk well below software industry norms. Across 11 independent financial models, InvestingPro estimates Adobe's Fair Valueat $407.67 per share, pointing to 63.7% upside. Investors can see in the Adobe Pro Research Report, 17 Wall Street analysts have revised earnings upward over the past 90 days as its AI-first annual recurring revenue climbed 150% year-over-year to surpass $650 million.
Track Adobe's valuation models and cash flow metrics: Access the ADBE Pro Research Report on InvestingPro
Non-cyclical cash generation with an exceptional dividend streak
While elevated interest rates tighten corporate budgets, they have virtually zero impact on essential medical care. As the world's largest healthcare platform generating $450.1 billion in trailing revenue, UnitedHealth Group (NYSE:UNH)operates largely insulated from higher borrowing costs.
That resilience showed up clearly in its latest results. In the third quarter, UnitedHealth posted adjusted earnings of $4.69 per share—beating consensus estimates by 13.8% and surging 60.6% year-over-year—prompting management to raise full-year profit guidance to at least $20.50 per share. Over the past twelve months, the company generated $26.2 billion in operating cash flow and returned $11.2 billion to shareholders year-to-date through buybacks and dividends, supported by a 16-year dividend growth streak. With a five-year beta of just 0.61, the business moves with far less volatility than debt-sensitive growth stocks.
Even with that predictable cash generation, UnitedHealth trades at a reasonable 19.8 times forward earnings near $414.13. Across five independent valuation models, InvestingPro estimates UnitedHealth's Fair Valueat $539.86 per share, pointing to 30.4% upside alongside a well-covered 2.3% dividend yield.
Focusing on earnings power over interest rate cuts
When the Federal Reserve leaves rates on hold, broad market multiple expansion tends to stall. In that environment, returns shift almost entirely onto operating fundamentals—rewarding businesses that generate reliable cash flow and fund their own operations without needing cheaper credit.
That focus underpins InvestingPro's screening models, which track balance-sheet solvency, margin durability, and return on equity to highlight resilient businesses. While UnitedHealth Group already features in premier strategies like Dominate the Dow and Best of Buffett, the broader selection of top-ranked compounders—along with the new additions arriving in the November 1st rebalance—can be tracked directly on InvestingPro.
For investors seeking a systematic approach to navigate an extended rate pause, full access costs just $9 a month.
Don't miss the November 1st rebalance: Unlock all top-rated ProPicks AI selections
Disclosure: The author holds no position in the stocks mentioned. Data and financial metrics as of October 28, 2026.
Original Article
Fed on hold? Two discounted blue chips built for high rates
Moody's cuts Cogent rating to Caa2 on mounting 2027 debt refinancing risks
Top nuclear stocks to watch amid sector pullback, says B Riley
